• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign.

作者信息

Wambier Carlos Gustavo, Vaño-Galván Sergio, McCoy John, Pai Suraj, Dhurat Rachita, Goren Andy

机构信息

Department of Dermatology, Alpert Medical School of Brown University, Providence, Rhode Island.

Dermatology Department, Ramón y Cajal Hospital, Madrid, Spain.

出版信息

J Am Acad Dermatol. 2020 Dec;83(6):e453-e454. doi: 10.1016/j.jaad.2020.07.099. Epub 2020 Jul 29.

DOI:10.1016/j.jaad.2020.07.099
PMID:32735970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7387285/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f16/7387285/258211302596/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f16/7387285/39553d829ba4/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f16/7387285/b43bf2becf9e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f16/7387285/258211302596/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f16/7387285/39553d829ba4/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f16/7387285/b43bf2becf9e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f16/7387285/258211302596/gr2_lrg.jpg

相似文献

1
Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign.新型冠状病毒肺炎中的雄激素性脱发：与有或无加布林征的年龄匹配的流行病学研究及医院结局的比较。
J Am Acad Dermatol. 2020 Dec;83(6):e453-e454. doi: 10.1016/j.jaad.2020.07.099. Epub 2020 Jul 29.
2
Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign".雄激素性脱发在大多数因新冠肺炎住院的患者中出现：“加布林征” 。
J Am Acad Dermatol. 2020 Aug;83(2):680-682. doi: 10.1016/j.jaad.2020.05.079. Epub 2020 May 22.
3
Androgenetic alopecia in COVID-19: Compared to what?新冠病毒感染中的雄激素性脱发：与什么相比？
J Am Acad Dermatol. 2020 Dec;83(6):e451. doi: 10.1016/j.jaad.2020.06.1031. Epub 2020 Jul 29.
4
Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall?生物钟基因可能驱动新冠病毒传染性的季节性变化：秋季我们会迎来第二波新冠疫情吗？
J Biol Regul Homeost Agents. 2020;34(4):1455-1457. doi: 10.23812/20-359-L-35.
5
Epidemiology of Covid-19.新型冠状病毒肺炎的流行病学
N Engl J Med. 2020 May 7;382(19):1869. doi: 10.1056/NEJMc2005157. Epub 2020 Mar 27.
6
Epidemiology of Covid-19. Reply.新型冠状病毒肺炎的流行病学。回复。
N Engl J Med. 2020 May 7;382(19):1869-1870. doi: 10.1056/NEJMc2005157. Epub 2020 Mar 27.
7
Male balding is a major risk factor for severe COVID-19.男性脱发是重症新冠病毒肺炎的一个主要风险因素。
J Am Acad Dermatol. 2020 Nov;83(5):e353-e354. doi: 10.1016/j.jaad.2020.07.062. Epub 2020 Jul 22.
8
Alopecia areata not due by isotretinoin. A thought in COVID-19 time.非异维A酸所致斑秃。新冠疫情期间的思考。
Dermatol Ther. 2020 Jul;33(4):e13451. doi: 10.1111/dth.13451. Epub 2020 May 5.
9
Association of androgenetic alopecia with a more severe form of COVID-19 infection.雄激素性脱发与 COVID-19 感染更严重形式相关。
Ir J Med Sci. 2023 Feb;192(1):187-192. doi: 10.1007/s11845-022-02981-4. Epub 2022 Mar 23.
10
Effects of 5-alpha reductase inhibitors on lung function: A reason for discontinuation during COVID-19 pandemic?5-α还原酶抑制剂对肺功能的影响：在新冠疫情期间停药的一个原因？
Dermatol Ther. 2020 Jul;33(4):e13535. doi: 10.1111/dth.13535. Epub 2020 May 20.

引用本文的文献

1
Recent Advances in the Role of Fibroblast Growth Factors in Hair Follicle Growth.成纤维细胞生长因子在毛囊生长中作用的最新进展
Biomolecules. 2025 Aug 20;15(8):1198. doi: 10.3390/biom15081198.
2
Evaluating the Role of the Gabrin Sign in Predicting COVID-19 Severity Among Patients with Androgenic Alopecia.评估加布林征在预测雄激素性脱发患者新冠病毒病严重程度中的作用。
Int J Trichology. 2025 Jan-Feb;17(1):54-57. doi: 10.4103/ijt.ijt_5_23. Epub 2025 Jun 23.
3
A Comment on Coronavirus Disease 2019 and the Hair.关于2019冠状病毒病与头发的评论

本文引用的文献

1
Androgenetic alopecia in COVID-19: Compared to what?新冠病毒感染中的雄激素性脱发：与什么相比？
J Am Acad Dermatol. 2020 Dec;83(6):e451. doi: 10.1016/j.jaad.2020.06.1031. Epub 2020 Jul 29.
2
Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign".雄激素性脱发在大多数因新冠肺炎住院的患者中出现：“加布林征” 。
J Am Acad Dermatol. 2020 Aug;83(2):680-682. doi: 10.1016/j.jaad.2020.05.079. Epub 2020 May 22.
3
Androgen sensitivity gateway to COVID-19 disease severity.雄激素敏感性是 COVID-19 疾病严重程度的关键。
Int J Trichology. 2024 Jan-Dec;16(1-6):1-5. doi: 10.4103/ijt.ijt_179_20. Epub 2025 Apr 18.
4
Photobiostimulation Therapy (PBST) and Pulsed Electromagnetic Field Therapy (PEMF) in Hair Loss Treatment: Multicentric, Retrospective, Case-Control Study.光生物刺激疗法（PBST）和脉冲电磁场疗法（PEMF）在脱发治疗中的应用：多中心、回顾性、病例对照研究。
Aesthetic Plast Surg. 2025 Mar;49(5):1193-1204. doi: 10.1007/s00266-024-04569-y. Epub 2024 Dec 4.
5
Systematic review: Impact of stem cells-based therapy, and platelet-rich plasma in hair loss and telogen effluvium related to COVID-19.系统评价：基于干细胞的疗法及富血小板血浆对与COVID-19相关的脱发和休止期脱发的影响
Regen Ther. 2023 Jul 21;24:267-273. doi: 10.1016/j.reth.2023.07.001. eCollection 2023 Dec.
6
Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial.普罗芦卡胺（GT0918）治疗 COVID-19 重症或危重症患者的疗效和安全性：一项前瞻性、开放标签、单臂、单中心探索性试验的研究方案。
BMC Pharmacol Toxicol. 2023 Jun 15;24(1):38. doi: 10.1186/s40360-023-00678-7.
7
Preliminary Investigation on Micro-Needling with Low-Level LED Therapy and Growth Factors in Hair Loss Related to COVID-19.低能量LED光疗法联合生长因子微针治疗新冠肺炎相关脱发的初步研究
J Clin Med. 2022 Sep 28;11(19):5760. doi: 10.3390/jcm11195760.
8
Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies.与 COVID-19 相关的脱发和休止期脱发：脂肪来源间充质干细胞和富血小板血浆作为再生策略的潜在意义。
Int J Mol Sci. 2022 Aug 14;23(16):9116. doi: 10.3390/ijms23169116.
9
Association of androgenetic alopecia with a more severe form of COVID-19 infection.雄激素性脱发与 COVID-19 感染更严重形式相关。
Ir J Med Sci. 2023 Feb;192(1):187-192. doi: 10.1007/s11845-022-02981-4. Epub 2022 Mar 23.
10
Systematic investigation of a potential epidemiological and genetic association between male androgenetic alopecia and COVID-19.男性雄激素性脱发与新型冠状病毒肺炎之间潜在的流行病学和遗传学关联的系统研究。
Skin Health Dis. 2021 Dec;1(4):e72. doi: 10.1002/ski2.72. Epub 2021 Oct 21.
Drug Dev Res. 2020 Nov;81(7):771-776. doi: 10.1002/ddr.21688. Epub 2020 May 15.
4
Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors.40 - 69岁男性雄激素性脱发：患病率及危险因素
Br J Dermatol. 2003 Dec;149(6):1207-13. doi: 10.1111/j.1365-2133.2003.05565.x.
5
Male pattern baldness: classification and incidence.男性型秃发：分类与发病率
South Med J. 1975 Nov;68(11):1359-65. doi: 10.1097/00007611-197511000-00009.